AbbVie Inc.
AbbVie Inc. (ABBV) — Form 8-K: Current report
AI-generated summary
AbbVie Inc. filed a current report regarding an executive or director change. On October 28, 2026, Class II director Jennifer L. Davis notified the Board of her intent to resign, effective November 2, 2026. Her resignation followed her recent appointment as Chief Executive Officer at Align Technology, Inc. and was not due to any dispute with AbbVie.
Key facts
- Item 5.02 · Executive or director change or pay arrangement
More ABBV filings
- 8-K
Filed Oct 30, 2026
- 3
Filed Oct 23, 2026
- 8-K
Filed Oct 15, 2026
- 8-K
Filed Oct 5, 2026
- 4
Filed Oct 2, 2026
- 4
Filed Oct 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.